InMed Pharmaceuticals Inc. INM
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -58.82% | 10.45% | 29.95% | 10.66% | 21.29% |
| Total Depreciation and Amortization | 42.73% | 4.08% | -23.11% | -30.94% | -33.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 415.54% | -454.18% | -362.61% | -272.01% | -236.92% |
| Change in Net Operating Assets | 160.08% | -271.71% | -139.45% | 111.39% | 51.50% |
| Cash from Operations | 14.21% | 13.15% | -6.33% | -18.70% | -15.94% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | 164.22% | 164.22% | -33.32% | -0.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -103.30% | 1,811.43% | 1,811.43% | 658.45% | 839.26% |
| Cash from Financing | -101.12% | 96.19% | 831.03% | 105.66% | 163.66% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -269.84% | 166.51% | 152.38% | 395.65% | 278.21% |